Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination
- 20 January 2005
- journal article
- applied genetics-and-molecular-biotechnology
- Published by Springer Science and Business Media LLC in Applied Microbiology and Biotechnology
- Vol. 68 (2), 220-227
- https://doi.org/10.1007/s00253-004-1869-y
Abstract
The nucleocapsid (N) protein of the severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) is an important antigen for the early diagnosis of SARS and the development of vaccines. It was expressed in Escherichia coli as a fusion with human glutathione S-transferase (hGST) and was confirmed by Western blotting analysis. This recombinant N protein (hGST-N) was purified and used to measure the SARS-CoV N-specific antibody in the sera of eight SARS patients by enzyme-linked immunosorbent assay. Specific antibody response to this purified recombinant N protein was 100% positive in the SARS patients’ sera, while none of the control sera from 30 healthy people gave a positive reaction in the same assay. The SARS-CoV N protein was also expressed in Lactococcus lactis in the cytoplasm or secreted into the medium. The N-producing strain MG1363/pSECN and the purified hGST-N protein were respectively administered to mice, either orally or intranasally. Results indicated that orally delivered MG1363/pSECN induced significant N-specific IgG in the sera. In conclusion, our work provides a novel strategy to produce the SARS-CoV N protein for serodiagnosis and for L. lactis-based mucosal vaccines.Keywords
This publication has 18 references indexed in Scilit:
- Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARSJournal of Clinical Virology, 2004
- Detection of Specific Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein for Serodiagnosis of SARS Coronavirus PneumoniaJournal of Clinical Microbiology, 2004
- Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccineImmunology Letters, 2004
- Profile of Antibodies to the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Probable SARS PatientsClinical and Vaccine Immunology, 2004
- Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV EnvBlood, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Heterologous Expression of an Immunogenic Pneumococcal Type 3 Capsular Polysaccharide in Lactococcus lactisInfection and Immunity, 2000
- Quorum sensing-controlled gene expression in lactic acid bacteriaJournal of Biotechnology, 1998
- Oral vaccination of mice against tetanus with recombinant Lactococcus lactisNature Biotechnology, 1997